February 12, 2018 / 9:44 PM / 13 days ago

BRIEF-VistaGen Therapeutics Reports Qtrly Loss Per Share $‍0.25​

Feb 12 (Reuters) - VistaGen Therapeutics Inc:

* VISTAGEN THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS

* VISTAGEN THERAPEUTICS INC QTRLY LOSS PER SHARE $‍0.25​

* VISTAGEN THERAPEUTICS INC - ‍AT DEC 31, HAD CASH, CASH EQUIVALENTS OF ABOUT $13.0 MILLION, COMPARED TO ABOUT $2.9 MILLION AT MARCH 31, 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below